| Product NDC: | 55566-7185 |
| Proprietary Name: | Repronex |
| Non Proprietary Name: | menotropins |
| Active Ingredient(s): | & nbsp; menotropins |
| Administration Route(s): | INTRAMUSCULAR; SUBCUTANEOUS |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55566-7185 |
| Labeler Name: | Ferring Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021047 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990827 |
| Package NDC: | 55566-7185-2 |
| Package Description: | 5 CARTON in 1 CARTON (55566-7185-2) > 1 KIT in 1 CARTON (55566-7185-0) * 2 mL in 1 VIAL, SINGLE-USE * 2 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 55566-7185-2 |
| Proprietary Name | Repronex |
| Package Description | 5 CARTON in 1 CARTON (55566-7185-2) > 1 KIT in 1 CARTON (55566-7185-0) * 2 mL in 1 VIAL, SINGLE-USE * 2 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 55566-7185 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | menotropins |
| Dosage Form Name | KIT |
| Route Name | INTRAMUSCULAR; SUBCUTANEOUS |
| Start Marketing Date | 19990827 |
| Marketing Category Name | NDA |
| Labeler Name | Ferring Pharmaceuticals |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |